Sérgio Rizzo

3.0k total citations
74 papers, 2.0k citations indexed

About

Sérgio Rizzo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sérgio Rizzo has authored 74 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 32 papers in Pulmonary and Respiratory Medicine and 18 papers in Molecular Biology. Recurrent topics in Sérgio Rizzo's work include Lung Cancer Treatments and Mutations (17 papers), Colorectal Cancer Treatments and Studies (13 papers) and Lung Cancer Research Studies (10 papers). Sérgio Rizzo is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Colorectal Cancer Treatments and Studies (13 papers) and Lung Cancer Research Studies (10 papers). Sérgio Rizzo collaborates with scholars based in Italy, United States and Argentina. Sérgio Rizzo's co-authors include Antonio Russo, Viviana Bazan, Antonio Galvano, Giuseppe Bronte, Daniele Santini, Francesco Passiglia, Angela Listì, Marta Castiglia, Giuseppe Cicero and Lorena Incorvaia and has published in prestigious journals such as Cancer, Scientific Reports and Annals of the New York Academy of Sciences.

In The Last Decade

Sérgio Rizzo

71 papers receiving 1.9k citations

Peers

Countries citing papers authored by Sérgio Rizzo

Since Specialization

Citations

This map shows the geographic impact of Sérgio Rizzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sérgio Rizzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sérgio Rizzo more than expected).

Fields of papers citing papers by Sérgio Rizzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sérgio Rizzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sérgio Rizzo. The network helps show where Sérgio Rizzo may publish in the future.

Co-authorship network of co-authors of Sérgio Rizzo

This figure shows the co-authorship network connecting the top 25 collaborators of Sérgio Rizzo. A scholar is included among the top collaborators of Sérgio Rizzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sérgio Rizzo. Sérgio Rizzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety profiles of the new target therapies—pemigatinib, futibatinib, and ivosidenib—for the treatment of cholangiocarcinoma: a systematic review 2025 ·Therapeutic Advances in Drug Safety ·(unknown), (unknown), (unknown), (unknown), Sérgio Rizzo, Alessio Provenzani	0
2	Efficacy and Safety of Antibody-Drug Conjugates for Lung Cancer Therapy: A Systematic Review of Randomized and Non-Randomized Clinical Trials 2025 ·Pharmaceutics ·(unknown), (unknown), Anna Maria Gallina, (unknown), Sérgio Rizzo, Alessio Provenzani	3
3	Cardiotoxicity associated with immune checkpoint inhibitors: Systematic review and meta-analysis 2024 ·Critical Reviews in Oncology/Hematology ·L Piazza, (unknown), (unknown), (unknown), (unknown), Alessio Provenzani, Sérgio Rizzo	8
4	Oxidative stability parameters and sensory properties of in-shell "Stuart" pecans [Carya illinoinensis (Wangenh.) K.Koch] stored at different temperatures under non-accelerated conditions 2021 ·Postharvest Biology and Technology ·A.M. Descalzo, Andrea Biolatto, Sérgio Rizzo, Carolina D. Pérez, (unknown), F. Carduza, Luciana Rossetti	9
5	How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials 2019 ·Critical Reviews in Oncology/Hematology ·Daniele Santini, Antonio Galvano, Francesco Pantano, Lorena Incorvaia, Sérgio Rizzo, Bruno Vincenzi, (unknown), Giovanna Giuliana, Fiorella Guadagni, Francesca Toia, Giuseppe Tonini, Antonio Russo, Giuseppe Badalamenti, Viviana Bazan	6
6	Oxidative status of a yogurt-like fermented maize product containing phytosterols 2018 ·Journal of Food Science and Technology ·A.M. Descalzo, Sérgio Rizzo, Adrien Servent, Luciana Rossetti, Marc Lebrun, Carolina D. Pérez, Renaud Boulanger, Christian Mestres, Dominique Pallet, Claudie Dhuique‐Mayer	12
7	Publisher Correction: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 2018 ·Scientific Reports ·Francesco Passiglia, Sérgio Rizzo, Massimo Di Maïo, Antonio Galvano, Giuseppe Badalamenti, Angela Listì, Leonardo Gulotta, Marta Castiglia, Fabio Fulfaro, Viviana Bazan, Antonio Russo	6
8	Plum (Prunus salicina) peel and pulp microparticles as natural antioxidant additives in breast chicken patties 2017 ·Food Research International ·María F. Basanta, Sérgio Rizzo, Natalia Szerman, Sergio Ramón Vaudagna, A.M. Descalzo, Lía N. Gerschenson, Carolina D. Pérez, Ana M. Rojas	39
9	The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials 2017 ·Critical Reviews in Oncology/Hematology ·Sérgio Rizzo, Antonio Galvano, Francesco Pantano, Michele Iuliani, Bruno Vincenzi, Francesco Passiglia, Silvia Spoto, Giuseppe Tonini, Viviana Bazan, Antonio Russo, Daniele Santini	14
10	The resistance related to targeted therapy in malignant pleural mesothelioma: Why has not the target been hit yet? 2016 ·Critical Reviews in Oncology/Hematology ·Giuseppe Bronte, Lorena Incorvaia, Sérgio Rizzo, Francesco Passiglia, Antonio Galvano, Fabio Rizzo, Christian Rolfo, Daniele Fanale, Angela Listì, Clara Natoli, Viviana Bazan, Antonio Russo	24
11	Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 2014 ·Expert Opinion on Drug Safety ·Giuseppe Bronte, Enrico Bronte, Giuseppina Novo, (unknown), (unknown), (unknown), F. Bronte, Eliana Gulotta, Sérgio Rizzo, Christian Rolfo, Nicola Silvestris, Viviana Bazan, Salvatore Novo, Antonio Russo	31
12	Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 2013 ·Critical Reviews in Oncology/Hematology ·Giuseppe Bronte, Christian Rolfo, Elisa Giovannetti, Giuseppe Cicero, Patrick Pauwels, Francesco Passiglia, Marta Castiglia, Sérgio Rizzo, (unknown), Eugenio Fiorentino, Jan P. van Meerbeeck, Antonio Russo	58
13	Co‐expression of CD133⁺/CD44⁺ in human colon cancer and liver metastasis 2012 ·Journal of Cellular Physiology ·Antonia Bellizzi, Sinto Sebastian, (unknown), (unknown), Rosa Divella, (unknown), Amalia Azzariti, Nicola Silvestris, Severino Montemurro, (unknown), Raffaele De Luca, Giuseppe Cicero, Sérgio Rizzo, Antonio Russo, Michele Quaranta, Giovanni de Simone, Angelo Paradiso	42
14	Vandali : l'assalto alle bellezze d'Italia 2011 ·Rizzoli eBooks ·(unknown), Sérgio Rizzo	1
15	PML expression in soft tissue sarcoma: Prognostic and predictive value in alkylating agents/antracycline‐based first line therapy 2011 ·Journal of Cellular Physiology ·Bruno Vincenzi, Daniele Santini, Gaia Schiavon, Anna Maria Frezza, Marianna Silletta, Pierfilippo Crucitti, Paolo G. Casali, Angelo Paolo Dei Tos, Sabrina Rossi, Sérgio Rizzo, Giuseppe Badalamenti, Rosa Maria Tomasino, Antonio Russo, James E. Butrynski, Giuseppe Tonini	3
16	Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura‐hemolytic uremic syndrome: the role of rituximab 2010 ·Transfusion ·Domenica Caramazza, Gerlando Quintini, (unknown), Alessandra Malato, Giorgia Saccullo, Lucio Lo Coco, (unknown), (unknown), Rita Barone, Giuseppina Mazzola, Sérgio Rizzo, Paolo Ragonese, Paolo Aridon, Vincenzo Abbadessa, Sergio Siragusa	32
17	Bevacizumab in association with de Gramont 5‐fluorouracil/folinic acid in patients with oxaliplatin‐, irinotecan‐, and cetuximab‐refractory colorectal cancer 2009 ·Cancer ·Bruno Vincenzi, Daniele Santini, Antonio Russo, Chiara Spoto, Olga Venditti, (unknown), Sérgio Rizzo, Bruno Beomonte Zobel, Marco Caricato, Sergio Valeri, Roberto Coppola, Giuseppe Tonini	28
18	Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? 2008 ·Breast Cancer Research and Treatment ·Antonio Russo, Valentina Calò, (unknown), (unknown), Valentina Agnese, Sandra Cascio, (unknown), Daniele Fanale, Sérgio Rizzo, Francesca Di Gaudio, Eliana Gulotta, Eva Surmacz, Gaetana Di Fede, Viviana Bazan	21
19	Prevalence of tobacco use in Eritrea: Results from a noncommunicable disease risk factor survey 2007 ·Nicotine & Tobacco Research ·J Mufunda, (unknown), (unknown), Peter Nyarangó, Abdulmumini Usman, Goitom Mebrahtu, Andrew Kosia, (unknown), (unknown), Yohannes Ghebrat, (unknown), Sérgio Rizzo, (unknown), (unknown)	4
20	Intercellular Communication and Human Hepatocellular Carcinoma 2004 ·Annals of the New York Academy of Sciences ·Giuseppe Carruba, Letizia Cocciadiferro, Vincenzo Bellavia, Sérgio Rizzo, Christos Tsatsanis, Demetrios�� Spandidos, Paola Muti, Colin P. Smith, Parmender P. Mehta, L. Castagnetta	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact